Moreover, it has been demonstrated that ATF3 is an androgen-regulated gene, and anti-androgen treatment decreases ATF3 expression in androgen-sensitive prostate cancer cells (LNCaP cells), whereas forced ATF3 overexpression stimulates androgen-insensitive prostate cancer cell (DU145 cells) proliferation [16]. This evidence concerns the gene ATF3 and prostate cancer.